ABSTRACT
In the process of pharmacokinetic and pharmacodynamic (PK/PD) modeling, it is important to
describe, prospectively, the objectives of the modeling, the study design, and the available PK
and PD data. The assumptions of the model can be related to dose-response, PK, PD, or one or
more of the assumptions listed in Table 1.
